Results 41 to 50 of about 24,187 (251)

Rhegmatogenous retinal detachment masquerading as exudative panuveitis with intense anterior chamber inflammatory reaction. [PDF]

open access: yes, 2020
Purpose:This is a retrospective case report illustrating the diagnostic and therapeutic challenges associated with a chronic rhegmatogenous retinal detachment masquerading as a severe panuveitis with intense anterior chamber inflammation.
Bhisitkul, Robert B   +3 more
core  

High prevalence of anelloviruses in vitreous fluid of children with seasonal hyperacute panuveitis. [PDF]

open access: yes, 2012
Seasonal hyperacute panuveitis (SHAPU) is a potentially blinding ocular disease occurring in Nepal that principally affects young children. Random amplification of partially purified vitreous fluid (VF)-derived nucleic acid revealed the presence of human
Baarsma, G Seerp   +8 more
core   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

New Interpretation of Galileo\u2019s Arthritis and Blindness [PDF]

open access: yes, 2015
Galileo Galilei (1564-1642) complained of several disorders during his life, the most important of which were chronic arthritic pains and bilateral blindness.
Barbieri, Cesare   +7 more
core   +2 more sources

Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes [PDF]

open access: yes, 2010
OBJECTIVE This trial tested whether mycophenolate mofetil (MMF) alone or with daclizumab (DZB) could arrest the loss of insulin-producing β-cells in subjects with new-onset type 1 diabetes.
Gottlieb, Peter A.   +10 more
core   +2 more sources

Recommendations for treatment of non-infectious uveitis [PDF]

open access: yesMedicinski casopis, 2018
© 2018, Serbian Medical Society. All right reserved. Having in mind that ophthalmologists are coping with the problems of optimizing uveitis treatment on daily basis, there is a need for more precise elaboration of the treatment. This paper presents recommendations for the treatment of noninfectious uveitis on the basis of professional opinion, years ...
Stanojevic Paovic, Anka   +6 more
openaire   +3 more sources

PCR em tempo real em uveites infecciosas como um diagnóstico alternativo [PDF]

open access: yes, 2011
PURPOSE: Uveitis is a major visual impairment disease affecting parts or the entire uveal tract and occasionally the sclera, the cornea or the optic nerve.
Belfort, Rubens Junior   +10 more
core   +2 more sources

Treatment of uveitis and scleritis patients in Malaysia [PDF]

open access: yesInternational Journal of Ophthalmology
AIM: To determine the common causes and visual outcome after treatment among uveitis and scleritis patients. METHODS: This is a retrospective cohort observational study.
Sieng Teng Seow   +4 more
doaj   +1 more source

Histomorphology of the healthy fellow eye in the rabbit with unilaterally induced non-infectious anterior and intermediate uveitis

open access: yesJournal of Ophthalmology, 2020
Background: It is important to use objective methods for assessing intraocular inflammation in the practical management of uveitis. Previously, we have found that, on day 1 of unilaterally induced non-infectious anterior and intermediate uveitis in ...
O. Dorokhova   +3 more
doaj   +1 more source

Analysis of the human diseasome reveals phenotype modules across common, genetic, and infectious diseases [PDF]

open access: yes, 2014
Phenotypes are the observable characteristics of an organism arising from its response to the environment. Phenotypes associated with engineered and natural genetic variation are widely recorded using phenotype ontologies in model organisms, as are signs
Gkoutos, Georgios V   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy